ZIMLAB — Zim Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹5.21bn
- IN₹6.22bn
- IN₹3.67bn
- 43
- 37
- 43
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.14 | ||
| Price to Tang. Book | 2.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.39 | ||
| EV to EBITDA | 14.75 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.9% | ||
| Return on Equity | 7.86% | ||
| Operating Margin | 6.96% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,777.39 | 3,072.63 | 3,334.27 | 3,985.27 | 3,674.24 | n/a | n/a | 1.84% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -78.88 | +234.07 | +31.91 | -42.99 | -30.67 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- February 14th, 1984
- Public Since
- June 8th, 2018
- No. of Shareholders
- 17,500
- No. of Employees
- 556
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 48,725,814
- Address
- Sadoday Gyan (Ground Floor), NAGPUR, 440013
- Web
- https://www.zimlab.in/
- Phone
- +91 7122981960
- Auditors
- Walker Chandiok & Co LLP
Upcoming Events for ZIMLAB
Zim Laboratories Ltd Annual Shareholders Meeting
Q1 2025 Zim Laboratories Ltd Earnings Release
Q2 2025 Zim Laboratories Ltd Earnings Release
Similar to ZIMLAB
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Zim Laboratories share price?
As of Today at 18:19 UTC, shares in Zim Laboratories are trading at IN₹105.04. This share price information is delayed by 15 minutes.
How has the Zim Laboratories share price performed this year?
Shares in Zim Laboratories last closed at IN₹105.04 and the price had moved by -0.29% over the past 365 days. In terms of relative price strength the Zim Laboratories share price has underperformed the S&P BSE 100 Index by -23.81% over the past year.
What are the analyst and broker recommendations for Zim Laboratories?
There is no consensus recommendation for this security.
What is the Zim Laboratories dividend yield?
Zim Laboratories does not currently pay a dividend.
Does Zim Laboratories pay a dividend?
Zim Laboratories does not currently pay a dividend.
When does Zim Laboratories next pay dividends?
Zim Laboratories does not currently pay a dividend.
How do I buy Zim Laboratories shares?
To buy shares in Zim Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zim Laboratories?
As of the previous close price of IN₹105.04, shares in Zim Laboratories had a market capitalisation of IN₹5.12bn.
Where are Zim Laboratories shares listed?
Here are the trading details for Zim Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ZIMLAB
What kind of share is Zim Laboratories?
Based on an overall assessment of its quality, value and momentum Zim Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zim Laboratories share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Zim Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zim Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -21.54%.
As of the last closing price of IN₹105.04, shares in Zim Laboratories were trading -6.03% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zim Laboratories PE Ratio?
The Zim Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹105.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zim Laboratories?
Zim Laboratories' management team is headed by:
- Shyam Patro - CFO
- Niraj Dhadiwal - VBD
- Anwar Daud - MDR